CAR T-cells Targeting CD20-positive Non-Hodgkin’s Lymphoma Safe and Effective, Long-term Study Shows – Lymphoma News Today
Lymphoma News Today |
CAR T-cells Targeting CD20-positive Non-Hodgkin's Lymphoma Safe and Effective, Long-term Study Shows
Lymphoma News Today A long-term follow-up study of immunotherapy with CAR T-cells in patients with B-cell non-Hodgkin's lymphoma with CD20-carrying B-cells show the approach is similar in effectiveness and safety to the more common CAR T-cell therapy. The study, published … |
